TMC435 HPC1004 - Phase I Study Investigating the Pharmacokinetics of TMC435 in Healthy Chinese Volunteers
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics, safety and tolerability of
single and multiple oral doses of TMC435 in Chinese healthy volunteers. Pharmacokinetics (PK)
means how the drug is absorbed into the bloodstream, distributed in the body and eliminated
from the body.